↧
Image may be NSFW.
Clik here to view.
Clik here to view.
Cipher readies regulatory filings for acne product
Cipher Pharmaceuticals (TSX:DND) is on track to file Health Canada and FDA submissions this quarter for its high-potential acne product, CIP-Isotretinoin, which is expected to trigger a $1 million...
View Article